Unlocking the Future of Alzheimer’s Treatment: Anavex2-73’s Groundbreaking Clinical Data Revealed at AAIC 2022
Anavex Announces Breakthrough in Alzheimer’s Disease Research Introduction: A recent study has revealed promising results in the treatment of Alzheimer’s and Parkinson’s disease through the use of ANAVEX®2-73. The expression levels of pathological dysregulated neurodegenerative genes associated with both diseases showed significant restoration after receiving this therapeutic treatment. Study Findings: The study showed that ANAVEX®2-73…